pharma
MSD scoops up biopharma firm Tilos for $773 million
June 10, 2019Sales and Marketing MSD, Tilos Therapeutics, acquisition, pharma
US-based firm MSD has announced it intends to acquire biopharma firm Tilos Therapeutics, and has signed a deal with the …
Sanofi’s Soliqua proves superior to GLP-1 RA therapies in reducing blood sugar levels
June 10, 2019Research and Development, Sales and Marketing Sanofi, Soliqua, diabetes, pharma, type 2 diabetes
Sanofi has stepped up at the American Diabetes Association (ADA) 79th Scientific Sessions in San Francisco, revealing new data which …
Novo’s oral semaglutide tops Jardiance and Victoza in two type 2 diabetes trials
June 10, 2019Research and Development, Sales and Marketing Novo Nordisk, diabetes, pharma, semaglutide, type 2 diabetes
Novo Nordisk has taken the opportunity at the American Diabetes Association (ADA) 79th Scientific Sessions to pull back the curtain …
FDA advisory panel backs TB Alliance’s tuberculosis regimen
June 10, 2019Sales and Marketing FDA, TB Alliance, US, pharma, tuberculosis
An FDA advisory panel has voted to recommend the investigational drug pretomanid, developed by the non-profit organisation TB Alliance, as …
Vectura CEO to step down at end of June
June 10, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, pharma, vectura
Vectura is on course for a new leader to take up the company’s reins after it was revealed that CEO …
Implementing “the safest medicines system in the world”
June 10, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, packaging, pharma
With debates heating up over cooperation between European across the continent, Matt Fellows investigates the current state of packaging countermeasures …
Long-term BMS exec Johanna Mercier joins Gilead as new Chief Commercial Officer
June 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma
Gilead Sciences have said Bristol-Myers Squibb exec Johanna Mercier will be the firm’s new Chief Commercial Officer. In her new …
Novartis Pharma head to become new Sanofi CEO
June 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Paul Hudson, Sanofi, appointment, olivier brandicourt, pharma
French drugmaker Sanofi has revealed that its CEO Olivier Brandicourt is to retire from the role, to be replaced with …
Mallinckrodt illegally inflated price of drug from $50 to $32,000, DoJ lawsuit says
June 7, 2019Business Services Achthar, DoJ, Mallinckrodt, Medicare, co-pay, pharma
The Department of Justice (DoJ) has filed new charges against Mallinckrodt alleging the Irish-listed firm illegally hiked the price of …
Otsuka to take over Astellas’ Cefixime business
June 7, 2019Medical Communications APIs, Antibiotics, Astellas, Otsuka, antimicrobial, pharma
Japanese firm Otsuka Chemical has bought Astellas Pharma’s antibiotic Cefixime. The agreement gives Otsuka the right to sell Cefixime and …
Healthcare communications: Time to think differently with patient centricity
June 6, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Spink, UK, patient centricity, pharma
Patient centricity, derived from the NHS-driven thinking “no decision about me, without me,” has been adopted by pharma to understand …
Battling cervical cancer in the developing world
June 6, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Doctors Without Borders, Medecins sans frontieres; cancer, cervical cancer, malawi, pharma
The non-profit humanitarian organization Medecins Sans Frontieres, or Doctors Without Borders, is well known for its work fighting on the …
First-of-its-kind data shows Novartis’ iscalimab extends survival of transplanted kidneys
June 6, 2019Research and Development Novartis, iscalimab, kidney transplant, pharma, transplant
In a first-of-its-kind reveal, Novartis has presented histology data for iscalimab (CFZ533) at the American Transplant Congress (ATC) which indicates …
Takeda’s Ninlaro fails to meet one of two primary endpoints in Phase 3 trial
June 6, 2019Research and Development TOURMALINE-AL1, Takeda, pharma, phase 3, trial Ninlaro
Takeda has decided to discontinue its Phase 3 study of Ninlaro (ixazomib) after the drug in combination with dexamethasone, failed …
Pfizer supressed research suggesting arthritis drug Enbrel reduced risk of Alzheimer’s by 64%
June 6, 2019Research and Development Alzheimer's, Drug therapy, Pfizer, dementia, pharma
Pfizer supressed data suggesting that their drug Enbrel reduced the risk of patients developing Alzheimer’s disease by 64%. In 2015, …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
